Not recommended for use in children, pregnancy and lactation. Dopamine-receptor- blocking agents elevate prolactin levels; the elevation persists during chronic administration. In the event that the patient develops galactorrhea and/or gynecomastia, withdrawal of the drug will result in alleviation of these symptoms.